These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31634632)

  • 1. Assessing the Financial Toxicity of Radiation Oncology Patients Using the Validated Comprehensive Score for Financial Toxicity as a Patient-Reported Outcome.
    D'Rummo KA; Miller L; TenNapel MJ; Shen X
    Pract Radiat Oncol; 2020; 10(5):e322-e329. PubMed ID: 31634632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the Prevalence of Financial Toxicity, its Predictors and Association with Health- Related Quality of Life Among Radiation Oncology Patients in India: A Cross-Sectional Patient Reported Outcome Study.
    Dar MA; Chauhan R; Trivedi V; Kumar R; Dhingra S
    Int J Radiat Oncol Biol Phys; 2023 May; 116(1):157-165. PubMed ID: 36455689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two validated instruments to measure financial hardship in cancer survivors: comprehensive score for financial toxicity (COST) versus personal financial wellness (PFW) scale.
    D'Rummo KA; Nganga D; Chollet-Hinton L; Shen X
    Support Care Cancer; 2022 Dec; 31(1):12. PubMed ID: 36513902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring financial toxicity in Australian cancer patients - Validation of the COmprehensive Score for financial Toxicity (FACT COST) measuring financial toxicity in Australian cancer patients.
    Durber K; Halkett GK; McMullen M; Nowak AK
    Asia Pac J Clin Oncol; 2021 Aug; 17(4):377-387. PubMed ID: 33567158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST).
    de Souza JA; Yap BJ; Wroblewski K; Blinder V; Araújo FS; Hlubocky FJ; Nicholas LH; O'Connor JM; Brockstein B; Ratain MJ; Daugherty CK; Cella D
    Cancer; 2017 Feb; 123(3):476-484. PubMed ID: 27716900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the financial toxicity in Tunisian cancer patients using the Comprehensive Score for Financial Toxicity (COST).
    Mejri N; Berrazega Y; Boujnah R; Rachdi H; El Benna H; Labidi S; Boussen H
    Support Care Cancer; 2021 Jul; 29(7):4105-4111. PubMed ID: 33404807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Financial toxicity in gynecologic oncology.
    Bouberhan S; Shea M; Kennedy A; Erlinger A; Stack-Dunnbier H; Buss MK; Moss L; Nolan K; Awtrey C; Dalrymple JL; Garrett L; Liu FW; Hacker MR; Esselen KM
    Gynecol Oncol; 2019 Jul; 154(1):8-12. PubMed ID: 31053404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financial toxicity in patients with cancer attending a public Australian tertiary hospital: A pilot study.
    McLean L; Hong W; McLachlan SA
    Asia Pac J Clin Oncol; 2021 Jun; 17(3):245-252. PubMed ID: 32894819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical Trials.
    Huey RW; George GC; Phillips P; White R; Fu S; Janku F; Karp DD; Naing A; Piha-Paul S; Subbiah V; Tsimberidou AM; Pant S; Yap TA; Rodon J; Meric-Bernstam F; Shih YT; Hong DS
    Oncologist; 2021 Jul; 26(7):588-596. PubMed ID: 33783054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessening the Impact of Financial Toxicity (LIFT): a protocol for a multi-site, single-arm trial examining the effect of financial navigation on financial toxicity in adult patients with cancer in rural and non-rural settings.
    Wheeler SB; Biddell CB; Manning ML; Gellin MS; Padilla NR; Spees LP; Rogers CD; Rodriguez-O'Donnell J; Samuel-Ryals C; Birken SA; Reeder-Hayes KE; Petermann VM; Deal AM; Rosenstein DL
    Trials; 2022 Oct; 23(1):839. PubMed ID: 36192802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Financial Burden Among Patients With Lung Cancer in a Publically Funded Health Care System.
    Ezeife DA; Morganstein BJ; Lau S; Law JH; Le LW; Bredle J; Cella D; Doherty MK; Bradbury P; Liu G; Sacher A; Shepherd FA; Leighl NB
    Clin Lung Cancer; 2019 Jul; 20(4):231-236. PubMed ID: 30797721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-reported financial toxicity in multiple sclerosis: Predictors and association with care non-adherence.
    Sadigh G; Lava N; Switchenko J; Duszak R; Krupinski EA; Meltzer C; Hughes D; Carlos RC
    Mult Scler; 2021 Mar; 27(3):453-464. PubMed ID: 32808562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients Undergoing Radiation Therapy Are at Risk of Financial Toxicity: A Patient-based Prospective Survey Study.
    Palmer JD; Patel TT; Eldredge-Hindy H; Keith SW; Patel T; Malatesta T; DiNome J; Lowther A; Ferguson L; Wagenborg S; Smyles J; Babaria U; Stabile R; Gressen E; Rudoler S; Fisher SA
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):299-305. PubMed ID: 29726359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying a cut-off score for the COST measure to indicate high financial toxicity and low quality of life among cancer patients.
    Ng MSN; Choi KC; Chan DNS; Wong CL; Xing W; Ho PS; Au C; Chan M; Tong M; Ling WM; Chan M; Mak SSS; Chan RJ; So WKW
    Support Care Cancer; 2021 Oct; 29(10):6109-6117. PubMed ID: 33797583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Financial toxicity in gynecologic oncology: a multi-practice survey.
    Smith AJ; Sharma MH; Powell K; Doherty M; Hinkle SN; Ko EM
    Int J Gynecol Cancer; 2024 Jun; 34(6):919-925. PubMed ID: 38346844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-reported financial toxicity and adverse medical consequences in head and neck cancer.
    Beeler WH; Bellile EL; Casper KA; Jaworski E; Burger NJ; Malloy KM; Spector ME; Shuman AG; Rosko A; Stucken CL; Chinn SB; Dragovic AF; Chapman CH; Owen D; Jolly S; Bradford CR; Prince MEP; Worden FP; Jagsi R; Mierzwa ML; Swiecicki PL
    Oral Oncol; 2020 Feb; 101():104521. PubMed ID: 31877502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Financial Toxicity Screening Tool for Radiation Oncology: A Secondary Analysis of a Pilot Prospective Patient-Reported Outcomes Study.
    Prasad RN; Patel TT; Keith SW; Eldredge-Hindy H; Fisher SA; Palmer JD
    Adv Radiat Oncol; 2021; 6(6):100782. PubMed ID: 34660939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Financial Toxicity in Crohn's Disease.
    Voit A; Cross RK; Bellavance E; Bafford AC
    J Clin Gastroenterol; 2019; 53(10):e438-e443. PubMed ID: 30358642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and financial toxicity in patients with renal cell carcinoma.
    Staehler MD; Battle DJ; Bergerot CD; Pal SK; Penson DF
    World J Urol; 2021 Jul; 39(7):2559-2565. PubMed ID: 33090258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with increased financial toxicity after the completion of radiation treatment for gynecologic cancer.
    Esselen KM; Baig RA; Gompers A; Stack-Dunnbier H; Hacker MR; Jang JW
    Support Care Cancer; 2023 Jun; 31(7):388. PubMed ID: 37300721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.